KATHRINE MOBISSON: Open Payments
NPI 1124102223 · ROSEVILLE, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$701 in 29 payments from 11 companies in 2025. Trend: 2023 $503 · 2024 $754 · 2025 $701
Food & beverage: $701
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 9 | $252 |
| Corium, LLC | 7 | $161 |
| Neurocrine BioSciences, Inc. | 3 | $64 |
| Collegium Pharmaceutical, Inc. | 2 | $58 |
| ABBVIE INC. | 2 | $41 |
| Teva Pharmaceuticals USA, Inc. | 1 | $29 |
| E.R. Squibb & Sons, L.L.C. | 1 | $27 |
| Bausch Health US, LLC | 1 | $21 |
| Alkermes, Inc. | 1 | $17 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
Products named: Auvelity, Azstarys, INGREZZA, Jornay PM, VRAYLAR, AUSTEDO XR, COBENFY, APLENZIN.
Industry payments across MI — which companies pay providers there.
